These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15250915)

  • 1. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.
    Blankestijn PJ; Ligtenberg G
    Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment].
    Neĭmark MI
    Ter Arkh; 1984; 56(9):102-5. PubMed ID: 6569758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract]   [Full Text] [Related]  

  • 4. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.
    Neumann J; Ligtenberg G; Klein II; Koomans HA; Blankestijn PJ
    Kidney Int; 2004 May; 65(5):1568-76. PubMed ID: 15086894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of the sympathetic nervous system and of the renin-angiotensin system in the acute stage of myocardial infarction].
    Renard M; Blankoff I; Chami J; Dereppe H; Chi Hoang H; Giot JM; Dramaix M; Bernard R
    Bull Mem Acad R Med Belg; 1991; 146(6-7):305-11. PubMed ID: 1815813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
    Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
    J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 8. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney and hypertension-causes. Update 2003.
    Ritz E; Adamczak M; Zeier M
    Herz; 2003 Dec; 28(8):663-7. PubMed ID: 14689099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal profile of dipper and non-dipper patients with essential hypertension.
    Lapiński M; Lewandowski J; Januszewicz A; Kuch-Wocial A; Symonides B; Wocial B; Januszewicz W
    J Hypertens Suppl; 1993 Dec; 11(5):S294-5. PubMed ID: 8158392
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
    Wang AY; Li PK; Lui SF; Sanderson JE
    Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of changes in the sodium balance on plasma catecholamines and renin activity at rest and on their response to orthostatic stimulation in arterial hypertension].
    Morganti A; Pickering T; Lopez-Ovejero J; Laragh J
    Minerva Nefrol; 1981; 28(3):261-4. PubMed ID: 7036014
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms.
    Kooman JP; van der Sande FM; Leunissen KM
    Blood Purif; 2004; 22(1):55-9. PubMed ID: 14732812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current data on the renin-angiotensin-aldosterone system. II. Involvement in infantile pathology].
    Goţia S
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(4):573-8. PubMed ID: 7170508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sympathetic nervous system and renin-angiotensin-aldosterone system in hypertension].
    Iwanami J; Mogi M; Horiuchi M
    Nihon Rinsho; 2011 Nov; 69(11):1916-9. PubMed ID: 22111308
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of mildly increasing dialysis sodium removal on renin and sympathetic system in hemodialysis patients.
    Shen Y; Sun F; Liu J; Ma L; Huang J; Zhou Y; Liu W
    Chin Med J (Engl); 2014; 127(14):2628-31. PubMed ID: 25043079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension control with daily dialysis.
    Saad E; Charra B; Raj DS
    Semin Dial; 2004; 17(4):295-8. PubMed ID: 15250921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodialysis-associated hypertension; pathophysiology and therapy].
    Suzuki H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():220-4. PubMed ID: 15250299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension in children. II. The pathogenetic mechanisms involved in arterial hypertension and the therapeutic correlates].
    Moraru D
    Pediatrie (Bucur); 1992; 41(3):46-59. PubMed ID: 1327233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.